Immunic, Inc. (IMUX): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2026-05-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

90.15M
As of 2025-12-31
13.64M
As of 2026-06-30
+31.9%
3-year compound annual growth
2013-12-31: 606.2K2014-12-31: 23.98M2015-12-31: 30.47M2016-12-31: 32.14M2017-12-31: 42.37M2018-12-31: 847.0K2019-12-31: 10.74M2020-12-31: 21.17M2021-12-31: 26.34M2022-12-31: 39.31M2023-12-31: 45.18M2024-12-31: 90.15M2025-12-31: 90.15M90.15M
2013-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3190.15M0.0%2026-02-26, Balance as of period end
2024-12-3190.15M+99.5%2025-03-31, Balance as of period end
2023-12-3145.18M+14.9%2025-03-31, Balance as of period end
2022-12-3139.31Mn/c2024-02-22, Balance as of period end
2021-12-3126.34M+24.4%2023-02-23, Balance as of period end
2020-12-3121.17Mn/c2022-02-24, Balance as of period end
2019-12-3110.74Mn/m2021-02-26, Balance as of period end
2018-12-31847.0K-98.0%2020-03-16, Balance as of period end
2017-12-3142.37M+31.8%2019-03-04, Balance as of period end
2016-12-3132.14M+5.5%2018-03-13, Balance as of period end
2015-12-3130.47M+27.1%2017-03-07, Balance as of period end
2014-12-3123.98Mn/m2016-03-08, Balance as of period end
2013-12-31606.2Kn/a2015-03-20, Balance as of period end